Search Results
KEYNOTE-177 discussion: chemo-immunotherapy, pseudoprogression & biomarkers
KEYNOTE-177: final PFS analysis of pembrolizumab in patients with MSI-H/dMMR mCRC
KEYNOTE-177: translating results for patients and clinicians
Dr. Nazik Hammad presents Keynote-177 (GI cancer)
ASCO GI: updates in KEYNOTE-177, IMbrave150 & ClarIDHy
Redefining First- line Therapy in Metastatic Colon Cancer. The Keynote-177 Study.
2021 ASCO Direct Jacksonville | Colorectal Cancer Summary | Dr. Louise Connell
ASCO GI 2021: trial updates
Cancer Immunotherapy Workshop 2021 – Introduction to Imaging Applications in Immuno-Oncology
#CRCLive: Discussing Key Takeaways from the 2020 ASCO Annual Meeting
S1 Episode 1: When Should You Consider Immunotherapy in Colorectal Cancer?
Webinar recording on Biomarkers of Immunotherapy For Solid Tumors - Dr Nirmal Raut & Dr G Arun Kumar
